Parent‐to‐Child Information Disclosure in Pediatric Oncology
Pediatric Blood & Cancer · 2026
DOI: 10.1002/1545-5017.70098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Rachel A Kentor und 12 weiteren Autor:innen. Beteiligte Einrichtung: Eastern Michigan University, Ypsilanti, Michigan, USA. Hauptthemen laut MEDLINE: Neoplasms, Truth Disclosure, Parents, Parent-Child Relations. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Despite professional consensus regarding the importance of open communication with pediatric cancer patients about their disease, actual practice patterns of disclosure are understudied. Extant literature suggests a significant proportion of children are not told about their diagnosis/prognosis, which is purported to negatively impact child/family psychosocial adjustment. The present study sought to characterize parent‐to‐child disclosure practices across child development. Procedure Primary caregivers ( n = 301) of pediatric cancer patients aged 3–17 were recruited online or during outpatient infusion appointments to complete an anonymous, online survey about disclosure practices and parent/child/family functioning.
Results
More extensive disclosures were associated with older child age ( p < 0.001), more frequent child questions, and greater parental desire for child involvement in medical decision‐making ( p < 0.001). Immediately salient information like diagnosis, upcoming treatment, and acute side effects was disclosed sooner after diagnosis (median = 1 week) than distal eventualities like prognosis and long‐term side effects (median = 2 weeks). Most caregivers believed their child had a right to know about their illness, and would and did better cope emotionally and adhere to treatment. Barriers to disclosure for a minority of caregivers included fears that their child was too young and the caregivers’ own lack of preparedness to deal with the prognosis themselves or make the disclosures. Caregiver and child distress were strongly associated ( p < 0.001).
Conclusions
Results point to the complexity of illness‐related information disclosure and nuances with which recommendations must be approached. The broader family context in which disclosure occurs, as well as when and how information is disclosed, may influence child distress more than the content of disclosures itself.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eastern Michigan University, Ypsilanti, Michigan, USA.
- University of Michigan, Ann Arbor, Michigan, USA.
- Corewell Children's/William Beaumont University Hospital, Royal Oak, Michigan, USA.
- Hurley Children's Hospital, College of Human Medicine, Michigan State University, Flint, Michigan, USA.
ORCID-Profile: Rachel A Kentor
Zitieren
APA
Kentor, R. A., Hoodin, F., Byrd, M., Kullgren, K. A., LaLonde, L., Benkoske, L., Smith, P., Carson, D., MacDonald, K., Inoue, S., Kitchen, B., Gowans, K., & Yanik, G. A. (2026). Parent‐to‐Child Information Disclosure in Pediatric Oncology. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70098
Vancouver
Kentor RA, Hoodin F, Byrd M, Kullgren KA, LaLonde L, Benkoske L, et al. Parent‐to‐Child Information Disclosure in Pediatric Oncology. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70098
BibTeX
@article{Kentor2026,
author = {Kentor, Rachel A and Hoodin, Flora and Byrd, Michelle and Kullgren, Kristin A and LaLonde, Leah and Benkoske, Lauren and Smith, Patrick and Carson, Dawn and MacDonald, Karen and Inoue, Susumu and Kitchen, Brenda and Gowans, Kate and Yanik, Gregory A},
title = {Parent‐to‐Child Information Disclosure in Pediatric Oncology},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/1545-5017.70098}
}
EUVIMED